Rational development of multicomponent mRNA vaccine candidates against mpox
The re-emerging mpox (formerly monkeypox) virus (MPXV), a member of Orthopoxvirus genus together with variola virus (VARV) and vaccinia virus (VACV), has led to public health emergency of international concern since July 2022. Inspired by the unprecedent success of coronavirus disease 2019 (COVID-19...
Saved in:
| Main Authors: | Rong-Rong Zhang, Zheng-Jian Wang, Yi-Long Zhu, Wei Tang, Chao Zhou, Suo-Qun Zhao, Mei Wu, Tao Ming, Yong-Qiang Deng, Qi Chen, Ning-Yi Jin, Qing Ye, Xiao Li, Cheng-Feng Qin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2023-12-01
|
| Series: | Emerging Microbes and Infections |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/22221751.2023.2192815 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mpox multi-antigen mRNA vaccine candidates by a simplified manufacturing strategy afford efficient protection against lethal orthopoxvirus challenge
by: Jiawei Zeng, et al.
Published: (2023-12-01) -
A Single-Chain Mpox mRNA Vaccine Elicits Protective Immune Response in Mice
by: Qian Xu, et al.
Published: (2025-05-01) -
Rational mpox vaccine design: immunogenicity and protective effect of individual and multicomponent proteins in mice
by: Xueting Cheng, et al.
Published: (2025-12-01) -
An Mpox Multi-Antigen-Tandem Bivalent mRNA Candidate Vaccine Effectively Protects Mice Against the Vaccinia Virus
by: Jun Zuo, et al.
Published: (2025-03-01) -
mRNA Vaccine Against Mpox: A Promising Healthcare Strategy
by: Mohammad Shah Alam, et al.
Published: (2025-05-01)